Job title: Senior Director, Discovery Sciences, Design & Synthesis Sciences
Adam joined the Pfizer in February 2010 as an Associate Research Fellow and a labhead in charge of the Experimental Design Chemistry (EDC) – a group that focused on key portfolio projects with challenging medicinal chemistry design issues including covalent inhibitors, allosteric GPCR modulators and chemoproteomics. EDC helped drive candidate molecule discovery for programs in Rare Diseases, Neuroscience and Immunology highlighted by PF-06651600, a covalent JAK3 inhibitor currently in Phase 2b/3 trials for Alopecia Areata. Adam is currently a Senior Director in in charge of Pfizer’s Design and Synthesis Sciences (DSS) Group. DSS is platform medchem group located in Pfizer’s Discovery Sciences Department in Groton, CT which helps drive key Pfizer initiatives such as protein degradation, DNA-encoded library chemistry and selection analysis, phenotypic screening, vaccine protein design and small molecule purification.